|
|
Other links at Articles > Pharmacists |
| 1. |
Surfactant Protein D Reduced by Fluticasone in COPD
|
|
|
Although fluticasone with or without salmeterol does not alter systemic markers of inflammation in patients with COPD, the drugs do result in a significant reduction in the serum levels of the lung-specific surfactant protein D, Canadian researchers report. Reuters Health Information
|
| 3. |
WellPoint Sees Top Value for PBM Internally for Now
|
|
|
WellPoint Inc believes keeping its pharmacy benefit management business is the best way to extract value from the unit, but the health insurer will look at other options if such value is not achieved, its chief accounting officer said on Wednesday. Reuters Health Information
|
|
|
